Physician profile
James Rogan
NPI 1982704300
$903.88
in general payments reported to CMS, 2019-2025
13 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.76 · 2021: $27.40 · 2023: $286 · 2024: $150 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $256.65 | 2023-2025 | Ingrezza |
| Acadia Pharmaceuticals INC | $252.53 | 2023-2025 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $157.41 | 2023 | Nuedexta |
| Inspire Medical Systems, INC. | $54.83 | 2024 | Inspire |
| Pfizer INC. | $42.76 | 2019 | |
| Lundbeck LLC | $28.35 | 2024 | Rexulti |
| Avanos Medical | $27.40 | 2021 | |
| Linus Health, INC. | $24.69 | 2024 | Core Cognitive Evaluation |
| Novo Nordisk INC | $20.77 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $20.24 | 2025 | Austedo Xr |
| Glaxosmithkline, LLC. | $18.25 | 2025 | Benlysta |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.